Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy

[img]
Preview
s41598-020-57610-w.pdf - Published Version (3MB) | Preview
Available under license: Creative Commons Attribution

Timpani, Cara ORCID: 0000-0003-4567-4319, Goodman, Craig ORCID: 0000-0002-5874-7743, Stathis, Christos ORCID: 0000-0003-0064-9523, White, Jason D, Mamchaoui, Kamel, Butler-Browne, Gillian, Gueven, Nuri, Hayes, Alan ORCID: 0000-0003-1398-3694 and Rybalka, Emma ORCID: 0000-0002-4854-0036 (2020) Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy. Scientific Reports, 10. ISSN 2045-2322

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/40234
DOI https://doi.org/10.1038/s41598-020-57610-w
Official URL https://www.nature.com/articles/s41598-020-57610-w
Subjects Current > FOR Classification > 0601 Biochemistry and Cell Biology
Current > FOR Classification > 1109 Neurosciences
Current > FOR Classification > 1116 Medical Physiology
Current > Division/Research > Institute for Health and Sport
Keywords Duschenne Muscular Dystrophy; muscle; adenylosuccinic acid; purine nucleotide cycle metabolite; metabolism; mice
Citations in Scopus 8 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login